Hexavalent chromium reduction kinetics in rodent stomach contents

Chemosphere

Volumn 89, Issue 5, 2012, Pages 487-493

  Proctor, Deborah M ^a   Suh, Mina ^a   Aylward, Lesa L ^b   Kirman, Christopher R ^b   Harris, Mark A ^c   Thompson, Chad M ^c   Gürleyük, Hakan ^d   Gerads, Russell ^d   Haws, Laurie C ^e   Hays, Sean M ^b  

^a ToxStrategies Inc   (United States)

^b LLP   (United States)

^c ToxStrategies Inc   (United States)

^d Applied Speciation   (United States)

^e ToxStrategies Inc   (United States)

Author keywords

Hexavalent chromium; PBTK; Rodent stomach reduction kinetics; Speciated isotope dilution mass spectrometry (SIDMS)

Indexed keywords

DETOXIFICATION; EXTRAPOLATION; ISOTOPES; KINETICS; MASS SPECTROMETRY; PHYSIOLOGICAL MODELS; POTABLE WATER; RATE CONSTANTS; RATS; REDUCING AGENTS; RISK ASSESSMENT;

DETOXIFICATION PROCESS; HEXAVALENT CHROMIUM; PBTK; QUANTITATIVE MEASURES; REDUCTION KINETICS; SECOND ORDER KINETICS; SECOND-ORDER RATE CONSTANTS; SPECIATED ISOTOPE-DILUTION MASS SPECTROMETRY;

CHROMIUM COMPOUNDS;

CHROMIUM; DRINKING WATER;

ABSORPTION; BIOASSAY; BIOCHEMISTRY; CANCER; CHROMIUM; CONCENTRATION (COMPOSITION); DETOXIFICATION; DOSE-RESPONSE RELATIONSHIP; DRINKING WATER; MASS SPECTROMETRY; REACTION KINETICS; REDUCTION; RISK ASSESSMENT; RODENT; STOMACH CONTENT; TUMOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOASSAY; CONTROLLED STUDY; DYNAMICS; EX VIVO STUDY; FEMALE; FOOD; HUMAN; ISOTOPE DILUTION ASSAY; MALE; MASS SPECTROMETRY; MOUSE; NONHUMAN; QUANTITATIVE ANALYSIS; RAT; REDUCTION KINETICS; RISK ASSESSMENT; SALIVA; SMALL INTESTINE; STOMACH CONTENT; STOMACH SECRETION; TOXICOKINETICS;

MUS; RATTUS; RODENTIA;

EID: 84864510114     PISSN: 00456535     EISSN: 18791298     Source Type: Journal    
DOI: 10.1016/j.chemosphere.2012.04.065     Document Type: Article

References (32)

1. CDPH, 2011. Chromium-6 in drinking water: an overview of sampling results.
2. Collins B.J., Stout M.D., Levine K.E., Kissling G.E., Melnick R.L., Fennell T.R., Walden R., Abdo K., Pritchard J.B., Fernando R.A., Burka L.T., Hooth M.J. Exposure to hexavalent chromium resulted in significantly higher tissue chromium burden compared with trivalent chromium following similar oral doses to male F344/N rats and female B6C3F1 mice. Toxicol. Sci. 2010, 118:368-379.
3. De Flora S. Threshold mechanisms and site specificity in chromium(VI) carcinogenesis. Carcinogenesis 2000, 21:533-541.
4. De Flora S., Boido V. Effect of human gastric juice on the mutagenicity of chemicals. Mutat. Res., Genet. Toxicol. 1980, 77:307-315.
5. De Flora S., Badolati G.S., Serra D., Picciotto A., Magnolia M.R., Savarino V. Circadian reduction of chromium in the gastric environment. Mutat. Res. 1987, 192:169-174.
6. De Flora S., Camoirano A., Bagnasco M., Bennicelli C., Corbett G.E., Kerger B.D. Estimates of the chromium(VI) reducing capacity in human body compartments as a mechanism for attenuating its potential toxicity and carcinogenicity. Carcinogenesis 1997, 18:531-537.
7. de Zwart, L.L., Rompelberg, C.J.M., Spis, A.J.A.M., Welink, J., van Engelen, J.G.M., 1999. Anatomical and physiological differences between various species used in studies on the pharmacokinetics and toxicology of xenobiotics. The National Institute of Public Health and the Environment, Bilthoven, The Netherlands, RIVM, Report 623860010.
8. Donaldson R.M., Barreras R.F. Intestinal absorption of trace quantities of chromium. J. Lab. Clin. Med. 1966, 68:484-493.
9. Finley B.L., Kerger B.D., Katona M.W., Gargas M.L., Corbett G.C., Paustenbach D.J. Human ingestion of chromium (VI) in drinking water: pharmacokinetics following repeated exposure. Toxicol. Appl. Pharmacol. 1997, 142:151-159.
10. Friis-Hansen L., Sundler F., Li Y., Gillespie P.J., Saunders T.L., Greenson J.K., Owyang C., Rehfeld J.F., Samuelson L.C. Impaired gastric acid secretion in gastrin-deficient mice. Am. J. Physiol. 1998, 274:G561-G568.
11. Glendinning J.I., Smith J.C. Consistency of meal patterns in laboratory rats. Physiol. Behav. 1994, 56:7-16.
12. Gürleyük H., Wallschlager D. Determination of chromium(III) and chromium(VI) using suppressed ion chromatography inductively coupled plasma mass spectrometry. J. Anal. At. Spectrom. 2001, 16:926-930.
13. Ho A., Chin A. Circadian feeding and drinking patterns of genetically obese mice fed solid chow diet. Physiol. Behav. 1988, 43:651-656.
14. Huo D., Lu Y., Kingston H.M. Determination and correction of analytical biases and study on chemical mechanisms in the analysis of Cr(VI) in soil samples using EPA protocols. Environ. Sci. Technol. 1998, 32:3418-3423.
15. Ito S., Schofield G.C. Studies on the depletion and accumulation of microvilli and changes in the tubulovesicular compartment of mouse parietal cells in relation to gastric acid secretion. J. Cell Biol. 1974, 63:364-382.
16. Kararli T.T. Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals. Biopharm. Drug Dispos. 1995, 16:351-380.
17. McConnell E.L., Basit A.W., Murdan S. Measurements of rat and mouse gastrointestinal pH, fluid and lymphoid tissue, and implications for in-vivo experiments. J. Pharm. Pharmacol. 2008, 60:63-70.
18. Nagourney S.J., Wilson S.A., Buckley B., Kingston H.M., Yang S.Y., Long S.E. Development of a standard reference material for Cr(VI) in contaminated soil. J. Anal. At. Spectrom. 2008, 23:1550-1554.
19. NTP, 2008. NTP technical report on the toxicology and carcinogenesis studies of sodium dichromate dihydrate (CAS No. 7789-12-0) in F344/N rats and B6C3F1 mice (drinking water studies), NTP TR 546. NIH Publication No. 08-5887.
20. Rahman G.M., Kingston H.M., Towns T.G., Vitale R.J., Clay K.R. Determination of hexavalent chromium by using speciated isotope-dilution mass spectrometry after microwave speciated extraction of environmental and other solid materials. Anal. Bioanal. Chem. 2005, 382:1111-1120.
21. Simpson R.J., Peters T.J. Forms of soluble iron in mouse stomach and duodenal lumen: significance for mucosal uptake. Br. J. Nutr. 1990, 63:79-89.
22. Spector A.C., Smith J.C. A detailed analysis of sucrose drinking in the rat. Physiol. Behav. 1984, 33:127-136.
23. Stern A.H. A quantitative assessment of the carcinogenicity of hexavalent chromium by the oral route and its relevance to human exposure. Environ. Res. 2010, 110:798-807.
24. Stout M.D., Herbert R.A., Kissling G.E., Collins B.J., Travlos G.S., Witt K.L., Melnick R.L., Abdo K.M., Malarkey D.E., Hooth M.J. Hexavalent chromium is carcinogenic to F344/N rats and B6C3F1 mice after chronic oral exposure. Environ. Health Perspect. 2009, 117:716-722.
25. Thompson C.M., Sonawane B., Barton H.A., DeWoskin R.S., Lipscomb J.C., Schlosser P., Chiu W.A., Krishnan K. Approaches for applications of physiologically based pharmacokinetic models in risk assessment. J. Toxicol. Environ. Health, B: Crit. Rev. 2008, 11:519-547.
26. Thompson C.M., Haws L.C., Harris M.A., Gatto N.M., Proctor D.M. Application of the U.S. EPA mode of action Framework for purposes of guiding future research: a case study involving the oral carcinogenicity of hexavalent chromium. Toxicol. Sci. 2011, 119:20-40.
27. Thompson C.M., Proctor D.M., Haws L.C., Hebert C.D., Grimes S.D., Shertzer H.G., Kopec A.K., Hixon J.G., Zacharewski T.R., Harris M.A. Investigation of the mode of action underlying the tumorigenic response induced in B6C3F1 mice exposed orally to hexavalent chromium. Toxicol. Sci. 2011, 123:58-70.
28. Thompson C.M., Proctor D.M., Suh M., Haws L.C., Hebert C.D., Mann J.F., Shertzer H.G., Hixon J.G., Harris M.A. Comparison of the effects of hexavalent chromium in the alimentary canal of F344 rats and B6C3F1 mice following exposure in drinking water: implications for carcinogenic modes of action. Toxicol. Sci. 2012, 125:79-90.
29. U.S. EPA Guidelines for carcinogen risk assessment, EPA/630/P-03/001F. Risk Assessment Forum 2005, U.S. Environmental Protection Agency, Washington, DC.
30. U.S. EPA, 2006. Approaches for the application of physiologically-based pharmacokinetic (PBPK) models and supporting data in risk assessment, EPA/600/R-05/043F. U.S. Environmental Protection Agency, Washinton, DC.
31. U.S. EPA, 2011. Recommended use of body weight 3/4 as the default method in derivation of the oral reference dose, EPA/100/R11/0001, U.S. EPA Risk Assessment Forum, Washington, DC.
32. Zhitkovich A. Chromium in drinking water: sources, metabolism, and cancer risks. Chem. Res. Toxicol. 2011, 24:1617-1629.